Top 5 Stock Picks of Ryan Caldwell’s Chiron Investment

2. CVS Health Corporation (NYSE:CVS)

Stake Value of Chiron Investment Management: $32,077,000

Percentage of Chiron Investment Management’s 13F Portfolio: 5.07%

Number of Hedge Fund Holders: 61

CVS Health Corporation (NYSE:CVS) provides health services in the United States. The company operates through four segments, namely, Pharmacy Services, Retail/LTC, Health Care Benefits, and Corporate/Other.

This November, JPMorgan analyst Lisa Gill raised her price target on CVS Health Corporation (NYSE:CVS) to $115 from $107 and kept an Overweight rating on the shares, in light of “strong” third-quarter earnings.

For the third quarter of 2021, CVS Health Corporation (NYSE:CVS) registered an EPS of $1.97, beating estimates by $0.18. The company’s revenue for the quarter was $73.79 billion, up from $67.06 billion, which shows a year-over-year growth of 10.05%.

Insider Monkey’s research was able to spot CVS Health Corporation (NYSE:CVS) on 61 hedge fund portfolios by the end of the third quarter of 2021. The hedge funds’ stakes in the company were more than $1.06 billion.

ClearBridge Investments published its “Sustainability Leaders Strategy” second quarter 2021 investor letter, in which the firm mentioned CVS Health Corporation (NYSE:CVS). Here’s what the experts at ClearBridge had to say:

“Our differentiated positions in the health care sector also made strong contributions as the market began to reward the heavily discounted sector.CVS Health saw strength in its pharmacy benefits manager business as well as its managed care business, Aetna, helping to confirm our positive view of CVS’s repositioning of its business model from a dispensary model to a service model. With CVS store-based health care services offering patients better convenience, encouraging better health care compliance and ultimately lower costs, we believe the company is at the forefront of a changing mindset in the health care services sector.”